CRUK Consent Form Updates – MPN and Nivolumab with Relatlimab for melanoma
Dear All,
I am happy to inform you that the MPN consent forms have been reviewed and updated. Furthermore, a new consent form has been added form for Nivolumab with Relatlimab for melanoma.
All forms can be found here: www.cruk.org/sact_consent.
Please share this update with your clinical teams or forward to the appropriate lead cancer clinician in your organisation.
Any questions, please do let me know.
Best wishes,
Alia
Alia Nizam (she/her)
Specialist Oncology Pharmacist, CRUK Information Lead
